Searchable abstracts of presentations at key conferences in endocrinology

ea0014p405 | (1) | ECE2007

Predictors of bone mineral density in women with primary hyperparathyroidism

Gianotti Laura , Tassone Francesco , Pia Anna , Razzore Paola , Cesario Flora , Magro Giampaolo , Borretta Giorgio

Aim: Osteoporosis is common in postmenopausal women and in primary hyperparathyroidism (PHPT). PHPT is more prevalent in postmenopausal women. Aim of the present study was to investigate possible predictors of bone mineral density (BMD) in women with PHPT.Methods: 166 consecutive women with PHPT [age: 59.5±13.5 years; Asymptomatic/Symptomatic: 84/82; premenopausal/postmenopausal: 31/135; BMI: 25.6±4.8 kg/m2; PTH: 234.2±287.3 pg/...

ea0014p509 | (1) | ECE2007

Long-term pegvisomant treatment in acromegaly

Gasco Valentina , Mainolfi Alessandra , Giorgio Damiano De , Ghigo Ezio , Grottoli Silvia

In acromegalic patients not suitable for first-line surgical treatment, pharmacotherapy is a valuable choice. Depot somatostatin analogs (SSA) represent efficacious and well-tolerated drugs; however, they normalize hormonal parameters in no more than 65–75%. Pegvisomant (PEGA), a GH receptor antagonist, has been shown to normalize IGF-I levels in more than 90% of patients. We report our experience in 13 acromegalic patients (7 M, 6 F; age: 50.2±3.9 yrs; 7 macroadenom...

ea0056oc4.3 | Novel insights into prediabetes and type 2 diabetes | ECE2018

Effects of TRAIL delivery on an experimental model of type 2 diabetes and diabetic nephropathy

Bernardi Stella , Toffoli Barbara , Tisato Veronica , Lorenzon Andrea , Zauli Giorgio , Secchiero Paola , Fabris Bruno

Introduction: Experimental studies suggest that a circulating protein called TRAIL (TNF-related apoptosis-inducing ligand) has the potential to treat type 2 diabetes mellitus (T2DM). We have recently demonstrated that TRAIL delivery ameliorates T2DM in the high-fat diet-fed mouse. This study aimed at evaluating whether TRAIL had the potential to treat not only T2DM but also diabetic nephropathy.Methods/design: Based on this background, 15 male db/H mice ...

ea0056p58 | Adrenal cortex (to include Cushing's) | ECE2018

The diagnostic accuracy of increased late night salivary cortisol for Cushing’s Syndrome: a real-life prospective study

Ceccato Filippo , Marcelli Giorgia , Martino Marianna , Concettoni Carolina , Brugia Marina , Trementino Laura , Michetti Grazia , Arnaldi Giorgio

Introduction and aim: A prompt diagnosis of Cushing’s Syndrome (CS) in high-risk populations is mandatory: 1-mg dexamethasone suppression test (1-mg DST); late night salivary cortisol (LNSC) and urinary free cortisol (UFC) are recommend, despite thresholds calculated in retrospective studies. Our aim was to study the diagnostic accuracy of LNSC measured with chemiluminescence assay in a prospective study, confirming discrepancies with mass spectrometry (MS).<p class="...

ea0056p62 | Adrenal cortex (to include Cushing's) | ECE2018

Different biological and functional features in patients with Cushing’s disease harboring micro- or macro-adenomas

Ceccato Filippo , Martino Marianna , Pinelli Silvia , Trementino Laura , Barbot Mattia , Boscaro Marco , Arnaldi Giorgio , Scaroni Carla

Background: ACTH-secreting pituitary adenomas represent two-thirds of Cushing’s syndrome (CS), the so-called Cushing’s disease (CD). These tumors are sometimes >10 mm in maximal diameter (macro-CD), but the majority of them are <10 mm (micro-CD). The aim of this study was to compare baseline characteristics of patients with micro-CD and macro-CD.Materials and methods: Clinical, hormonal and radiological data of 226 patients with CD were...

ea0099ep311 | Adrenal and Cardiovascular Endocrinology | ECE2024

Impact of 10 years of conventional steroids vs dual-release hydrocortisone on metabolic, cardiovascular, and bone outcomes in treatment-naïve patients with adrenal insufficiency

Guarnotta Valentina , Di Stefano Claudia , Tomasello Laura , Pizzolanti Giuseppe , Arnaldi Giorgio , Giordano Carla

Patients with adrenal insufficiency show higher mortality than in the general population, mainly due to non-physiological daily glucocorticoid overexposure and to inadequate cortisol exposure during stress-related events and illness. The aim of the current study is to compare the impact of 10 years of conventional glucocorticoid (GC) replacement treatment and dual-release hydrocortisone (DR-HC), on anthropometric, metabolic, cardiovascular and bone outcomes in treatment-na&#23...

ea0081p22 | Adrenal and Cardiovascular Endocrinology | ECE2022

Mesenchymal Stem Cells exposed to persistently high glucocorticoid levels develop insulin-resistance and altered lipolysis: a promising in vitro model to study Cushing’s Syndrome

Di Vincenzo Mariangela , Martino Marianna , Lariccia Vincenzo , Giancola Giulia , Licini Caterina , Di Benedetto Giovanni Maria , Orciani Monia , Arnaldi Giorgio

Objective: In Cushing’s Syndrome, chronic glucocorticoid excess and their disrupted circadian rhythm lead to insulin-resistance, diabetes mellitus, dyslipidemia and cardiovascular comorbidities. As undifferentiated, self-renewing progenitors of adipocytes, mesenchymal stem cells may display the detrimental effects of glucocorticoid excess, thus revealing a promising model to study molecular mechanisms underlying metabolic complications of Cushing’s Syndrome.<p cl...

ea0081p547 | Calcium and Bone | ECE2022

Effect of bisphosphonates on vertebral fractures in HIV infected males: 7-years study

Chiara Pezzaioli Letizia , Porcelli Teresa , Storti Emanuele , Delbarba Andrea , Tiecco Giorgio , Castelli Francesco , Cappelli Carlo , Ferlin Alberto , Quiros-Roldan Eugenia

Objective: Osteoporosis and vertebral fractures (VFs) are frequently observed in HIV-infected men. Whereas bisphosphonates seem effective on bone mineral density (BMD) maintenance in HIV-men, data on VFs are lacking. We aimed to evaluate the long-term efficacy of bisphosphonates on VFs in HIV-infected men.Design: Real-life longitudinal retrospective study on 118 consecutive HIV-infected males (median age at inclusion 53 years). Median time between first ...

ea0081p412 | Pituitary and Neuroendocrinology | ECE2022

Sodium alterations impair the long-term prognosis of hospitalized patients with COVID-19 pneumonia: hospital readmissions and mortality rates after a 18-month follow-up

Martino Marianna , Aboud Nairus , Perrone Michele , Falcioni Paolo , Giancola Giulia , Ciarloni Alessandro , Salvio Gianmaria , Silvetti Francesca , Taccaliti Augusto , Arnaldi Giorgio

Background: Dysnatremia is common in hospitalized patients, often worsening the prognosis in pneumopathies and critical illnesses, such as COVID-19. Here, hyponatremia is an indicator of pulmonary involvement, while hypernatremia is associated with worse assistance outcomes, particularly when resulting from an overcorrected hyponatremia. Longer hospitalizations, readmissions after discharge and higher short- and long-term mortality rates have been observed in acute patients ex...

ea0081p718 | Thyroid | ECE2022

Clinical presentation and significance of thyroid dysfunctions secondary to PD-1/PD-L1 blockade cancer immunotherapy

Di Dalmazi Giulia , Elena Sorbo Sofia , Dudiez Andrea , Ciappini Beatrice , Cipolloni Ilaria , Russo Gianluca , Luisi Dimitri , Napolitano Giorgio , Bucci Ines

Background: Thyroid dysfunctions are among the most common immune-related adverse events (irAEs) following the administration of immune checkpoint inhibitors (ICIs) for malignancies. The pathogenesis of thyroid irAEs remains unclear and the clinical course can be multifaceted.Aim: Aims of this study were a) to describe the incidence and the clinical course of thyroid irAEs b) to determine the association between thyroid irAEs and overall survival (OS).</...